=== SUMMARY ===
- The author, a value investor, is contemplating buying into the "Magnificent 7" stocks after a recent market downturn, despite their historically high valuations.
- The author expresses strong skepticism about NVIDIA's future earnings, believing that its major customers (like Microsoft and Meta) will inevitably cut back on capital expenditures, negatively impacting NVIDIA's growth.
- Quality assessment: This is speculation and personal opinion. The author shares their portfolio philosophy and feelings (FOMO) but does not provide in-depth research or quantitative analysis to support their views.
=== SENTIMENT ===
MIXED
=== TRADE IDEAS ===
TICKER - DIRECTION | confidence: 0.75 | sentiment: -0.70
Speaker: u/Personal-Walrus-3682
Thesis:
1. THE FACT: The author has a high conviction that major tech companies like Microsoft (MSFT) and Meta (META) will cut back on their capital expenditures (CapEx).
2. THE BRIDGE: Since these companies are major customers for NVIDIA's AI hardware, a reduction in their spending will directly and negatively impact NVIDIA's future earnings and growth prospects.
3. THE VERDICT: The author believes NVIDIA is overvalued and poised for a significant decline as its primary revenue stream from cloud/AI infrastructure spending is likely to contract. They explicitly state they "can't imagine a robust earnings future for NVDA."
4. RISKS: CapEx from major tech companies could remain strong or even accelerate due to the ongoing AI arms race. New customers or markets could emerge, offsetting any potential slowdown from existing clients. The market may continue to price in long-term growth, ignoring near-term CapEx fluctuations.
Timeframe: medium-term
Key Points:
- Expects major customer CapEx to be cut back.
- Cannot imagine a robust earnings future for NVDA.
- Believes NVDA will weigh down the US market index.
- Actively avoids US market ETFs partly due to NVDA.
TICKER - DIRECTION | confidence: 0.55 | sentiment: +0.30
Speaker: u/Pers
Оценка27
Комментарии48
% апвоутов70%
▶ Полный текст поста
I have a couple dozen positions. I'll share MKL, KNSL, and FRFHF, also some biotech stocks (companies I worked for), and others that are over-valued like SIEGY, ROK, FANUY, ABBNY that I got in on early but I haven't sold because I think they're long term winners.
I used to own the Mag 7 via VTI, but I completely switched over to stock picking. I don't currently own any Mag 7 stocks.
Last year I watched many Mag 7 stocks soar, and I definitely felt some FOMO. The valuations are still pretty high despite the downturn, but I'm thinking of compromising some value investing convictions to buy great companies at a slight premium.
Just curious if other value oriented investors are considering buying Mag 7 stocks right now, or if you simply see the downturn as confirming your view that over-valued companies eventually regress to their true value.
Also, I'm looking for a bullish case for NVDA if anyone has one. I have high conviction that CapEx for MSFT, META, etc., is probably going to be cut back and I really can't imagine a robust earnings future for NVDA when that inevitably happens. NVDA is partly the reason I avoid US market ETFs. I suspect that company is going to weigh down the index for the next year or so.